Italia markets close in 7 hours 26 minutes
  • FTSE MIB

    21.432,74
    +225,49 (+1,06%)
     
  • Dow Jones

    29.260,81
    -329,60 (-1,11%)
     
  • Nasdaq

    10.802,92
    -65,00 (-0,60%)
     
  • Nikkei 225

    26.571,87
    +140,32 (+0,53%)
     
  • Petrolio

    78,03
    +1,32 (+1,72%)
     
  • BTC-EUR

    20.956,74
    +1.194,54 (+6,04%)
     
  • CMC Crypto 200

    461,33
    +28,23 (+6,52%)
     
  • Oro

    1.645,00
    +11,60 (+0,71%)
     
  • EUR/USD

    0,9639
    +0,0027 (+0,28%)
     
  • S&P 500

    3.655,04
    -38,19 (-1,03%)
     
  • HANG SENG

    17.867,19
    +12,05 (+0,07%)
     
  • Euro Stoxx 50

    3.388,39
    +45,83 (+1,37%)
     
  • EUR/GBP

    0,8928
    -0,0068 (-0,75%)
     
  • EUR/CHF

    0,9535
    -0,0010 (-0,11%)
     
  • EUR/CAD

    1,3171
    -0,0025 (-0,19%)
     

OPKO Health to Present at the 2022 Jefferies Healthcare Conference

·1 minuto per la lettura
Opko Health, Inc.
Opko Health, Inc.

MIAMI, June 02, 2022 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) today announced that management will be participating in the 2022 Jefferies Healthcare Conference taking place June 8-10, 2022 in New York City. Management will be participating in a fireside chat on Thursday, June 9th at 8:00 a.m. Eastern time and will be hosting one-on-one meetings with investors.

The fireside chat will be webcast live and available for replay in the Investors section of OPKO Health’s website by clicking here.

About OPKO Health

OPKO is a multinational biopharmaceutical and diagnostics company that seeks to establish industry-leading positions in large, rapidly growing markets by leveraging its discovery, development, and commercialization expertise and novel and proprietary technologies. For more information, visit www.opko.com.

Contacts:

LHA Investor Relations
Yvonne Briggs, 310-691-7100
ybriggs@lhai.com
or
Bruce Voss, 310-691-7100
bvoss@lhai.com